Dose and protocol policy

No suggested human doses or injection instructions are published.

Many catalogue compounds are investigational or unapproved, and a research-use label does not establish a safe consumer dose. Nexa provides evidence summaries and concentration arithmetic—not treatment protocols.

Product-by-product dosing status

1
Unapproved or investigational compoundsNo validated consumer dose is provided. Any legitimate research exposure belongs in an approved clinical trial or institutionally governed protocol.
2
Active ingredients that exist in approved medicinesThe Nexa research vial is not the approved branded medicine. Dosing depends on the exact approved product, indication, route, patient factors and official label.
3
Laboratory reference materialsAmounts and concentrations are determined by the validated assay or institutional SOP—not a consumer dosing chart.
4
Competitive sportAthletes must check the exact ingredient and current anti-doping rules. A website dose, research label or CoA does not make a substance permitted.

Why the uploaded injection charts are not used

They combine solvent choices, injection preparation, syringe-unit conversions, example doses and storage claims for products that may be unapproved or lack product-specific stability data. Nexa replaces these with a neutral concentration table that shows only total mass divided by entered volume.